Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS)

G Gan Zhang D Danfeng Yu H Huan Pan J Jiong Liu R Ruling Wang Y Yunyan Wan W Wuhua Zhou H Huaxiang Wang

Article Details

Volume / Issue Vol. 15, Issue 1
Published November 26, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

G

Gan Zhang

D

Danfeng Yu

H

Huan Pan

J

Jiong Liu

R

Ruling Wang

Y

Yunyan Wan

W

Wuhua Zhou

H

Huaxiang Wang